New drug cocktail aims to free aplastic anemia patients from transfusions
NCT ID NCT07523009
First seen Apr 20, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This study tests a combination of three drugs (cyclosporine, eltrombopag or hetrombopag, and romiplostim) in 43 adults newly diagnosed with severe aplastic anemia or a related condition requiring blood transfusions. The goal is to see if the treatment can restore blood cell production and reduce the need for transfusions. Participants must not have a suitable donor for a stem cell transplant or be unable to receive standard therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE APLASTIC ANEMIA (SAA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.